Summary
A critical analysis imaging system in cystoscopy to replace white light cystoscopy (WLC) should have a diagnostic accuracy, patient safety, cost-effectiveness and should be an easily available technology. The traditional WLC is prone to miss flat lesions such as the carcinoma in situ (CIS) and small papillary lesions. The newer advanced enhanced imaging systems in cystoscopy make these subtle lesions apparent in bladder thereby leading to more complete oncological clearance, reducing the rates of recurrence and progression and hence the quality of life and survival in carcinoma urinary bladder patients.